114 related articles for article (PubMed ID: 331648)
1. Adenocarcinoma of the prostate gland.
Boxer RJ
Urol Surv; 1977 Jun; 27(3):75-94. PubMed ID: 331648
[No Abstract] [Full Text] [Related]
2. Occult carcinoma of the prostate.
El-Morsi AR
J Egypt Med Assoc; 1974; 57(7-8):373-7. PubMed ID: 4452775
[No Abstract] [Full Text] [Related]
3. Screening for adenocarcinoma of the prostate.
Miles BJ
Henry Ford Hosp Med J; 1989; 37(1):5-7. PubMed ID: 2475458
[No Abstract] [Full Text] [Related]
4. The discovery of prostate specific antigen as a biomarker for the early detection of adenocarcinoma of the prostate.
Makarov DV; Carter HB
J Urol; 2006 Dec; 176(6 Pt 1):2383-5. PubMed ID: 17085105
[TBL] [Abstract][Full Text] [Related]
5. Prostatic adenocarcinoma of ductal origin.
Greene LF; Farrow GM; Ravits JM; Tomera FM
J Urol; 1979 Mar; 121(3):303-5. PubMed ID: 219263
[TBL] [Abstract][Full Text] [Related]
6. [New prospective diagnostic serum markers in prostatic cancer].
Mirone V; De Bellis G; Prezioso D; Sanseverino R; Iannucci F; Padulano P
Minerva Med; 1986 Mar; 77(13):503-4. PubMed ID: 2422605
[No Abstract] [Full Text] [Related]
7. Studies on prostatic cancer. I. The effect of castration, of estrogen and of androgen injection on serum phosphatases in metastatic carcinoma of the prostate. 1941.
Huggins C; Hodges CV
J Urol; 2002 Feb; 167(2 Pt 2):948-51; discussion 952. PubMed ID: 11905923
[No Abstract] [Full Text] [Related]
8. Carcinoma of the prostate presenting as obstructive carcinoma of the rectum.
Mir M; Dikranian H; Cogbill CL
Am Surg; 1973 Oct; 39(10):582-6. PubMed ID: 4728151
[No Abstract] [Full Text] [Related]
9. State of the art in immune diagnosis of early adenocarcinoma of the prostate.
Pontes JE
Urol Clin North Am; 1980 Oct; 7(3):667-74. PubMed ID: 7456178
[No Abstract] [Full Text] [Related]
10. The early diagnosis and radical cure of carcinoma of the prostate.
CA Cancer J Clin; 1977; 27(5):308-16. PubMed ID: 411553
[No Abstract] [Full Text] [Related]
11. [Prostatic cancer. Reliability of clinical staging and the prognostic significance of age, clinical stage and tumor morphology].
Mihatsch MJ; Rist M; Ohnacker H; Oberholzer M; Spichtin HP; Schmassmann A; Perret A; Torhorst J; Rutishauser G
Z Urol Nephrol; 1983 May; 76(5):281-97. PubMed ID: 6880416
[No Abstract] [Full Text] [Related]
12. [Clinical and pathological study of tumor marker in benign prostatic hypertrophy and incidental prostatic cancer].
Sakai N; Ogawa T; Ishibashi Y; Fukuoka H; Sakanishi S
Hinyokika Kiyo; 1991 Jun; 37(6):589-94. PubMed ID: 1716409
[TBL] [Abstract][Full Text] [Related]
13. Adenocarcinoma of the prostate gland.
Finkelstein LH
J Am Osteopath Assoc; 1983 Apr; 82(8):543-6. PubMed ID: 6853232
[No Abstract] [Full Text] [Related]
14. Adenocarcinoma of the prostate simulating primary rectal malignancy.
Olsen BS; Carlisle RW
Cancer; 1970 Jan; 25(1):219-22. PubMed ID: 5410312
[No Abstract] [Full Text] [Related]
15. [The diagnostic value of serum acid phosphatases in carcinoma of the prostate (author's transl)].
Braun JS; Habig H; Crüsemann D
Urologe A; 1974 Sep; 13(5):236-41. PubMed ID: 4138057
[No Abstract] [Full Text] [Related]
16. Prostatic acid phosphatase: clinical utility in detection, assessment, and monitoring carcinoma of the prostate.
Pappas AA; Gadsden RH
Ann Clin Lab Sci; 1984; 14(4):285-91. PubMed ID: 6465831
[TBL] [Abstract][Full Text] [Related]
17. [Prostatic adenocarcinoma. II. Study of diagnostic methods. Review of the literature].
Valls Fontanals A; Panadés Nigorra G; Ballester Moll T
Actas Urol Esp; 1985; 9(2):115-20. PubMed ID: 3893053
[No Abstract] [Full Text] [Related]
18. Monitoring and treatment of minimal residual cancer of the prostate.
Mathé G; Schally AV; Comaru-Schally AM; Mauvernay RY; Vovan ML; Machover D; Misset JL; Court B; Bouchard P; Duchier J
Suppl J Med Oncol Tumor Pharmacother; 1988; 1():65-74. PubMed ID: 3074228
[No Abstract] [Full Text] [Related]
19. [The role of PSA in prostatic adenocarcinoma].
Manca GP
Minerva Med; 1990 Apr; 81(4):261-4. PubMed ID: 1692981
[TBL] [Abstract][Full Text] [Related]
20. Histology, histochemistry, and acid phosphatase of Noble (Nb) rat prostate adenocarcinomas and treatment of an androgen-dependent Nb rat prostate adenocarcinoma.
Drago JR; Goldman LB; Maurer RE; Eckels DD; Gershwin ME
J Natl Cancer Inst; 1980 Apr; 64(4):931-7. PubMed ID: 6929004
[No Abstract] [Full Text] [Related]
[Next] [New Search]
